Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mulling over 200 pages of actuarial tables, bond portfolios, and mortality assumptions in Globe Life’s filings can drain hours. The insurer’s blend of life and supplemental health policies, an agent-driven distribution network, and a multi-billion-dollar fixed-maturity portfolio make each disclosure intricate. If you have ever searched for “Globe Life SEC filings explained simply” or wondered how a shift in interest rates ripples through policy reserves, you’re not alone.
Stock Titan’s platform turns that complexity into clarity. Our AI-powered summaries translate the fine print of a Globe Life annual report 10-K simplified, a Globe Life quarterly earnings report 10-Q filing, or a Globe Life 8-K material events explained into plain language you can act on. Receive real-time alerts for Globe Life Form 4 insider transactions — including Globe Life executive stock transactions Form 4 — and dig into Globe Life proxy statement executive compensation without wading through appendices. Need a quick Globe Life earnings report filing analysis? We highlight segment trends and mortality experience in seconds.
Professionals use our coverage to:
- Track Globe Life insider trading Form 4 transactions before market opens
- Compare underwriting margins across periods using AI-extracted tables
- Understand reserve adequacy by linking 10-K footnotes to investment yields
Whether you’re monitoring Globe Life 8-K updates on rating-agency actions or simply understanding Globe Life SEC documents with AI, every filing lands here the moment EDGAR posts it. Complex insurance disclosures made approachable — so you can focus on decisions, not paperwork.
Omeros Corporation (OMER) – Form 4 filing dated 07/01/2025
Non-employee director Thomas J. Cable reported the automatic annual equity award granted in connection with the company’s 06/27/2025 shareholder meeting:
- Security: Stock option (right to buy common shares)
- Quantity: 15,000 options
- Exercise price: $3.20 per share
- Expiration: 06/27/2035 (10-year term)
- Vesting: 100 % on the day before the 2026 annual meeting, contingent on continued board service
- Post-transaction holdings: 15,000 derivative securities held directly
The grant follows Omeros’ standard non-employee director compensation policy and does not reflect a purchase or sale of common stock. No other transactions were disclosed.